Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope.

J Cell Mol Med · 2007 · PMC3922346 · PMID 17635633

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Signs of hope A second generation of antiangiogenic trials is beginning to show highly significant potential [ 8, 35 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.